☆ 4.6 Article

The Evaluation of CYP2D6, CYP2C9, CYP2C19, and CYP2B6 Phenoconversion in Post-Mortem Casework: The Challenge of Forensic Toxicogenetics

METABOLITES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Genetics & Heredity

Pharmacogenomics: current status and future perspectives

Munir Pirmohamed

Summary: In this Review, the current state of the pharmacogenomics field is discussed, along with clinically relevant drug-gene associations and the steps required for implementing pharmacogenomics into clinical practice. The role of pharmacogenomics in drug discovery and development is also considered. The variability in drug response between individuals, which can be attributed to genomic factors, is a global concern. Despite the availability and decreasing cost of genotyping technologies, challenges in implementing pharmacogenomics lie in adapting current clinical pathways and addressing the knowledge gap in healthcare professionals. Furthermore, pharmacogenomics shows promise in enhancing drug discovery and development outcomes.

NATURE REVIEWS GENETICS (2023)

添加到收藏夹

Article Chemistry, Analytical

Development and validation of a fast UPLC-MS/MS screening method for the detection of 68 psychoactive drugs and metabolites in whole blood and application to post-mortem cases

Rossella Barone et al.

Summary: We developed a LC-MS/MS method for simultaneous detection of various antidepressants, benzodiazepines, neuroleptics, and metabolites in whole blood. The method was validated using commercial calibrators and showed good precision and accuracy. It can be a reliable screening tool for psychotropic drugs in postmortem samples.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2023)

添加到收藏夹

Review Genetics & Heredity

Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health

Yitian Zhou et al.

Summary: Variability in pharmacogenetic polymorphisms can affect the safety and efficacy of medical treatments, with differences observed between ethnogeographic groups. Understanding these differences is crucial for optimizing population-specific care strategies.

HUMAN GENETICS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function

Katalin Mango et al.

Summary: The CYP2B6 enzyme is a major catalyst for the metabolism of several important drugs, and its function varies greatly among individuals due to both genetic and non-genetic factors. A study found that hepatic CYP2B6 activity is strongly correlated with CYP2B6 mRNA expression, and that both genetic and non-genetic factors can contribute to a mismatch between CYP2B6 genotype and phenotype.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Review Chemistry, Medicinal

The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug-Drug Interactions: Drug-Gene, Drug-Gene-Gene and Drug-Drug-Gene Interactions

Martina Hahn et al.

Summary: Drug interactions are a common cause of adverse drug events, and databases can assist clinicians in recognizing and avoiding these interactions. However, not all interactions result in adverse drug events, as the genetic profile of the patient also plays a role in the clinical relevance of these interactions.

PHARMACEUTICALS (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

PharmVar GeneFocus: CYP2B6

Zeruesenay Desta et al.

Summary: PharmVar catalogs star (*) allele nomenclature for the polymorphic human CYP2B6 gene, which plays a significant role in the metabolism and bioactivation of several clinically important drugs, including those used for HIV treatment, opioid use disorder, depression, and smoking cessation.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions

Ramon Cacabelos et al.

Summary: Pharmacogenomics plays a crucial role in optimizing drug efficacy and safety in preventing adverse drug reactions, but its application in ADR prevention is hindered by limitations such as lack of education and training, unspecific biomarkers, cost-effectiveness issues, administrative challenges, and insufficient regulation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Genetics & Heredity

Pitfalls and challenges associated with phenoconversion in forensic toxcicology

G. Drevin et al.

Summary: This article highlights the importance of considering other determinants in forensic toxicology, using the original case of a heroin-related fatality. Results showed a discrepancy between genomic evaluation and observed metabolic ratio of VEN, possibly due to phenoconversion induced by drug interactions. Phenoconversion can have a significant impact on genotype-focused clinical outcomes correlation and forensic toxicology conclusions.

FORENSIC SCIENCE INTERNATIONAL-GENETICS (2021)

添加到收藏夹

Review Psychiatry

Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19

Anne B. Koopmans et al.

Summary: Extensive migration has highlighted the need for personalized pharmacological treatment for migrants of different ethnic backgrounds due to significant differences in drug metabolism capacities. Clinically relevant CYP2D6 and CYP2C19 enzymes play a crucial role in psychiatric medication. Global data indicates large inter-ethnic variations in the prevalence of non-normal metabolizer predicted phenotypes for CYP2D6 and CYP2C19.

TRANSLATIONAL PSYCHIATRY (2021)

添加到收藏夹

Review Environmental Sciences

Pharmacogenetics and Forensic Toxicology: A New Step towards a Multidisciplinary Approach

Nunzio Di Nunno et al.

Summary: Pharmacogenetics is a research field that analyzes the individual behavior of DNA genes after drug administration. Recent advancements in genome sequencing and molecular genetics have allowed for the implementation of pharmacogenetic research, which is crucial for clarifying toxicological data in post-mortem examinations and determining causes and modes of death. Several studies emphasize the importance of pharmacogenetics in drug-related deaths, especially in cases where drug abuse does not lead to overdoses.

TOXICS (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Sequence2Script: A Web-Based Tool for Translation of Pharmacogenetic Data Into Evidence-Based Prescribing Recommendations

Chad A. Bousman et al.

Summary: Pharmacogenomic (PGx) testing is increasingly used in clinics and the commercial industry, but not all tests have consistent standards for translating results into prescribing recommendations. Sequence2Script is a web-based tool designed to assist users in efficiently translating PGx testing results into evidence-based prescribing recommendations. This tool supports 97 gene-drug pairs and allows users to adjust recommendations, generating a clinical report summarizing patient genotype and prescribing recommendations. The hope is that Sequence2Script will help standardize the use of PGx testing results and reduce barriers to implementation in practice.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

How to Integrate CYP2D6 Phenoconversion into Clinical Pharmacogenetics: A Tutorial

Emily J. Cicali et al.

Summary: CYP2D6 genotype is increasingly used to guide medication prescribing. The drug metabolizing enzyme CYP2D6 can be inhibited by concomitant drugs, leading to clinical phenotype different from genotype. A calculator tool was built to assess CYP2D6 phenoconversion in practice, highlighting the need to consider various clinical factors.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine

Michelle Whirl-Carrillo et al.

Summary: Clinical annotations in PharmGKB summarize the association between variant-drug pairs and are assigned a level of evidence. To ensure consistency and transparency, a scoring system has been developed to automate LOE assignment. This system improves the quality and reliability of clinical annotations.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

添加到收藏夹

Article Medicine, Legal

Light cannabis consumption in a sample of young adults: Preliminary pharmacokinetic data and psychomotor impairment evaluation

Guido Pelletti et al.

Summary: The study examined the effects of smoking cannabis with low Delta 9-THC content on young adults, finding high variability in Delta 9-THC and CBD concentrations with no significant impairment in psychomotor performance.

FORENSIC SCIENCE INTERNATIONAL (2021)

添加到收藏夹

Article Pathology

Recommendations for Clinical CYP2D6 Genotyping Allele Selection A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy

Victoria M. Pratt et al.

Summary: The goals of the Association for Molecular Pathology Pharmacogenomics Working Group are to define the key attributes of pharmacogenetic alleles recommended for clinical testing and determine a minimal set of variants for clinical PGx genotyping assays. Recommendations for a minimal panel and an extended panel of variant alleles are provided to aid clinical laboratories in designing assays for PGx testing, with the ultimate goal of promoting standardization across clinical laboratories. The document focuses on clinical CYP2D6 PGx testing and serves as a reference guide for laboratories implementing or updating their PGx testing platforms.

JOURNAL OF MOLECULAR DIAGNOSTICS (2021)

添加到收藏夹

Review Genetics & Heredity

CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations-Implication for Drug Safety, Dosing, and Individualized Therapy

Immaculate M. Langmia et al.

Summary: Adverse drug reactions (ADRs) are major causes of morbidity and mortality worldwide, with individual genetic make-up being a contributing factor. Variability in the CYP2B6 gene, caused by single nucleotide polymorphisms (SNPs), can affect drug metabolism and lead to adverse drug reactions or therapeutic failure. Understanding the pharmacogenomics of CYP2B6 may be useful for developing personalized medicine based on genotype-based prescription.

FRONTIERS IN GENETICS (2021)

添加到收藏夹

Article Psychiatry

Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting

Sam Mostafa et al.

Summary: Polypharmacy and genetic variants influencing medication response are risk factors for adverse drug reactions. Phenoconversion affects the reporting of medications with actionable PGx guideline recommendations, especially for CYP2D6 and CYP2C19 intermediate metabolisers before and after discharge in acute aged persons mental health patients.

FRONTIERS IN PSYCHIATRY (2021)

添加到收藏夹

Article Medicine, General & Internal

Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report

Nicole Marie Del Toro-Pagan et al.

Summary: This case study demonstrates the impact of pharmacist-led medication evaluation with pharmacogenomic (PGx) testing and clinical decision support system (CDSS) in identifying and mitigating medication-related issues to optimize medication regimen and safety.

MEDICINA-LITHUANIA (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group

Kelly E. Caudle et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

A Scoping Review of the Evidence Behind Cytochrome P450 2D6 Isoenzyme Inhibitor Classifications

Emily J. Cicali et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs

Katherine N. Theken et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)

添加到收藏夹

Article Medicine, Legal

Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in post-mortem whole blood

Guido Pelletti et al.

FORENSIC SCIENCE INTERNATIONAL (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Pharmacogenomics of methadone: a narrative review of the literature

Senthil Packiasabapathy et al.

PHARMACOGENOMICS (2020)

添加到收藏夹

Review Medicine, General & Internal

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review

Sylvia D. Klomp et al.

JOURNAL OF CLINICAL MEDICINE (2020)

添加到收藏夹

Article Cell Biology

Diazepam Promotes Translocation of Human Constitutive Androstane Receptor (CAR) via Direct Interaction with the Ligand-Binding Domain

Josef Skoda et al.

CELLS (2020)

添加到收藏夹

Review Genetics & Heredity

A Review of the Important Role of CYP2D6 in Pharmacogenomics

Christopher Taylor et al.

GENES (2020)

添加到收藏夹

Review Toxicology

Inhibition and induction of CYP enzymes in humans: an update

Jukka Hakkola et al.

ARCHIVES OF TOXICOLOGY (2020)

添加到收藏夹

Article Clinical Neurology

An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes

Sam Mostafa et al.

JOURNAL OF NEURAL TRANSMISSION (2019)

添加到收藏夹

Article Genetics & Heredity

Structural variation at the CYP2C locus: Characterization of deletion and duplication alleles

Mariana R. Botton et al.

HUMAN MUTATION (2019)

添加到收藏夹

Article Medicine, Legal

Prevalence of therapeutic drugs in blood of drivers involved in traffic crashes in the area of Bologna, Italy

Guido Pelletti et al.

FORENSIC SCIENCE INTERNATIONAL (2019)

添加到收藏夹

Article Medicine, Legal

Supervised Classification of CYP2D6 Genotype and Metabolizer Phenotype With Postmortem Tramadol-Exposed Finns

Frank R. Wendt et al.

AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research

Rachel Huddart et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)

添加到收藏夹

Review Chemistry, Medicinal

Methadone Metabolism and Drug-Drug Interactions: In Vitro and In Vivo Literature Review

Donna A. Volpe et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2018)

添加到收藏夹

Article Anthropology

Genetic variability of CYP2D6, CYP2B6, CYP2C9 and CYP2C19 genes across the Italian Peninsula

Francesco Carano et al.

ANNALS OF HUMAN BIOLOGY (2018)

添加到收藏夹

Article Chemistry, Analytical

Tell-Tale SNPs: The Role of CYP2B6 in Methadone Fatalities

Taha Ahmad et al.

JOURNAL OF ANALYTICAL TOXICOLOGY (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Biosynthesis of Fluorinated Analogs of Drugs Using Human Cytochrome P450 Enzymes Followed by Deoxyfluorination and Quantitative Nuclear Magnetic Resonance Spectroscopy to Improve Metabolic Stability

R. Scott Obach et al.

DRUG METABOLISM AND DISPOSITION (2016)

添加到收藏夹

Article Pharmacology & Pharmacy

Addressing phenoconversion: the Achilles' heel of personalized medicine

Rashmi R. Shah et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)

添加到收藏夹

Article Pharmacology & Pharmacy

Differences in Methadone Metabolism by CYP2B6 Variants

Sarah Gadel et al.

DRUG METABOLISM AND DISPOSITION (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization

J. Kevin Hicks et al.

CURRENT DRUG METABOLISM (2014)

添加到收藏夹

Article Medicine, Legal

Pharmacogenetics in medico-legal context

A. Sajantila et al.

FORENSIC SCIENCE INTERNATIONAL (2010)

添加到收藏夹

Article Medicine, Legal

Pharmacogenetics and forensic toxicology

Frank Musshoff et al.

FORENSIC SCIENCE INTERNATIONAL (2010)

添加到收藏夹

Article Pharmacology & Pharmacy

Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients

Silvana Borges et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2010)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales

Johanna Sistonen et al.

PHARMACOGENETICS AND GENOMICS (2009)

添加到收藏夹

Article Pharmacology & Pharmacy

The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype

A. Gaedigk et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)

添加到收藏夹

Article Medicine, Legal

CYP2D6 and CYP2C19 genotypes and amitriptyline metabolite ratios in a series of medicolegal autopsies

A Koski et al.

FORENSIC SCIENCE INTERNATIONAL (2006)

添加到收藏夹

Review Pharmacology & Pharmacy

The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes

A Parkinson et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)

添加到收藏夹

Article Pharmacology & Pharmacy

Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population

MG Scordo et al.

PHARMACOLOGICAL RESEARCH (2004)

添加到收藏夹

Article Genetics & Heredity

A comparison of Bayesian methods for haplotype reconstruction from population genotype data

M Stephens et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.